粪便免疫化学检测OC-Light阳性结果后结肠镜检查的检出率
本研究为回顾性队列研究,纳入2010年8月至2015年6月在旧金山健康网络接受OC-Light粪便免疫化学检测(FIT)筛查结直肠癌的50-75岁患者,阳性者转诊结肠镜。结果显示FIT阳性患者中结直肠癌阳性预测值为3.0%,进展期腺瘤阳性预测值为20.8%。
要点
- OC-Light FIT阳性患者中结直肠癌阳性预测值为3.0%,进展期腺瘤为20.8%。
- 首轮FIT阳性率9.4%高于后续轮次7.4%(P < .01)。
- 首轮FIT阳性者结直肠癌检出率3.7%,后续轮次降至1.8%(P = .02)。
核心结论
- 在多样化安全网人群中,OC-Light FIT阳性患者约3%检出结直肠癌,约21%检出进展期腺瘤。
研究设计与样本
- 回顾性队列研究,纳入2010年8月至2015年6月在旧金山健康网络接受OC-Light FIT筛查的50-75岁患者,共收集35,318次FIT检测结果,涉及20,886例患者。
主要发现
- 2930例患者(8.3%)FIT阳性,其中1558例完成随访结肠镜检查。
- FIT阳性对结直肠癌的阳性预测值为3.0%,对进展期腺瘤的阳性预测值为20.8%。
- 首轮FIT阳性率为9.4%,后续轮次为7.4%(P < .01)。
- 首轮FIT阳性者结直肠癌检出率为3.7%,后续轮次为1.8%(P = .02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The fecal immunochemical test (FIT) is widely used in colorectal cancer (CRC) screening. The OC-Light FIT is 1 of 2 FITs recommended for CRC screening by the Preventive Services Task Force guidelines. However, little is known about its ability to detect CRC in large average-risk populations. METHODS: We performed a retrospective cohort study of patients (50-75 years old) in the San Francisco Health Network who were screened for CRC by OC-Light FIT from August 2010 through June 2015. Patients with a positive result were referred for colonoscopy. We used electronic health records to identify participants with positive FIT results, and collected results from subsequent colonoscopies and pathology analyses. The FIT positive rate was calculated by dividing the number of positive FIT results by the total number of FIT tests completed. The primary outcome was the positive rate from OC-Light FIT and yield of neoplasms at colonoscopy. Secondary outcomes were findings from first vs subsequent rounds of testing, and how these varied by sex and race. RESULTS: We collected result from 35,318 FITs, performed on 20,886 patients; 2930 patients (8.3%) had a positive result, and 1558 patients completed the follow-up colonoscopy. A positive result from the FIT identified patients with CRC with a positive predictive value of 3.0%, and patients with advanced adenoma with a positive predictive value of 20.8%. The FIT positive rate was higher during the first round of testing (9.4%) compared to subsequent rounds (7.4%) (P < .01). The yield of CRC in patients with a positive result from the first round of the FIT was 3.7%, and decreased to 1.8% for subsequent rounds (P = .02). CONCLUSIONS: In a retrospective analysis of patients in a diverse safety-net population who underwent OC-Light FIT for CRC screening, we found that approximately 3% of patients with a positive result from a FIT to have CRC and approximately 21% to have advanced adenoma.
引用
- Alsayid M, Singh MH, Issaka R, et al. Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light. Clin Gastroenterol Hepatol. 2018. PMID: 29660528. doi:10.1016/j.cgh.2018.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。